IFP Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $640K | Sell |
2,897
-3
| -0.1% | -$830 | 0.01% | 935 |
|
|
2026
Q1 | $857K | Buy |
2,900
+1,074
| +59% | +$319K | 0.02% | 751 |
|
|
2025
Q4 | $499K | Sell |
1,826
-104
| -5% | -$28.3K | 0.01% | 935 |
|
|
2025
Q3 | $521K | Buy |
1,930
+329
| +21% | +$89.5K | 0.01% | 846 |
|
|
2025
Q2 | $481K | Buy |
1,601
+31
| +2% | +$8.43K | 0.01% | 848 |
|
|
2025
Q1 | $417K | Sell |
1,570
-592
| -27% | -$146K | 0.01% | 838 |
|
|
2024
Q4 | $502K | Buy |
2,162
+1,290
| +148% | +$297K | 0.02% | 734 |
|
|
2024
Q3 | $193K | Sell |
872
-398
| -31% | -$82.4K | 0.01% | 1112 |
|
|
2024
Q2 | $250K | Sell |
1,270
-302
| -19% | -$62.4K | 0.01% | 926 |
|
|
2024
Q1 | $339K | Buy |
1,572
+128
| +9% | +$26.9K | 0.01% | 751 |
|
|
2023
Q4 | $304K | Sell |
1,444
-368
| -20% | -$78.5K | 0.01% | 763 |
|
|
2023
Q3 | $364K | Sell |
1,812
-600
| -25% | -$119K | 0.02% | 707 |
|
|
2023
Q2 | $447K | Buy |
2,412
+705
| +41% | +$130K | 0.02% | 693 |
|
|
2023
Q1 | $155K | Sell |
1,707
-3,286
| -66% | -$594K | 0.01% | 1053 |
|
|
2022
Q4 | $529K | Sell |
4,993
-181
| -3% | -$31.5K | 0.01% | 872 |
|
|
2022
Q3 | $550K | Buy |
5,174
+427
| +9% | +$84.4K | 0.01% | 882 |
|
|
2022
Q2 | $504K | Hold |
4,747
| – | – | 0.02% | 851 |
|
|
2022
Q1 | $504K | Buy |
4,747
+2,734
| +136% | +$642K | 0.02% | 851 |
|
|
2021
Q4 | $466K | Sell |
2,013
-172
| -8% | -$37.8K | 0.01% | 617 |
|
|
2021
Q3 | $433K | Sell |
2,185
-94
| -4% | -$19K | 0.01% | 631 |
|
|
2021
Q2 | $486K | Buy |
2,279
+161
| +8% | +$34K | 0.01% | 555 |
|
|
2021
Q1 | $436K | Buy |
2,118
+170
| +9% | +$33.5K | 0.01% | 564 |
|
|
2020
Q4 | $354K | Buy |
1,948
+281
| +17% | +$47.8K | 0.01% | 605 |
|
|
2020
Q3 | $279K | Sell |
1,667
-440
| -21% | -$74.1K | 0.02% | 592 |
|
|
2020
Q2 | $336K | Sell |
2,107
-305
| -13% | -$54.7K | 0.03% | 510 |
|
|
2020
Q1 | $423K | Sell |
2,412
-822
| -25% | -$164K | 0.04% | 388 |
|
|
2019
Q4 | $653K | Sell |
3,234
-33
| -1% | -$6.77K | 0.05% | 372 |
|
|
2019
Q3 | $694K | Buy |
+3,267
| New | +$683K | 0.05% | 398 |
|
|
2019
Q1 | $143K | Sell |
887
-1,529
| -63% | -$270K | 0.02% | 570 |
|
|
2018
Q4 | $450K | Sell |
2,416
-401
| -14% | -$74.1K | 0.03% | 593 |
|
|
2018
Q3 | $479K | Sell |
2,817
-2,937
| -51% | -$494K | 0.02% | 677 |
|
|
2018
Q2 | $943K | Buy |
5,754
+125
| +2% | +$20.4K | 0.04% | 431 |
|
|
2018
Q1 | $822K | Hold |
5,629
| – | – | 0.04% | 454 |
|
|
2017
Q4 | $822K | Buy |
5,629
+3,230
| +135% | +$460K | 0.04% | 455 |
|
|
2017
Q3 | $326K | Sell |
2,399
-599
| -20% | -$75.7K | 0.01% | 886 |
|
|
2017
Q2 | $375K | Buy |
2,998
+71
| +2% | +$8.49K | 0.02% | 800 |
|
|
2017
Q1 | $348K | Buy |
2,927
+635
| +28% | +$76.4K | 0.02% | 846 |
|
|
2016
Q4 | $264K | Buy |
2,292
+296
| +15% | +$32.9K | 0.01% | 909 |
|
|
2016
Q3 | $209K | Sell |
1,996
-521
| -21% | -$54.4K | 0.01% | 987 |
|
|
2016
Q2 | $245K | Buy |
2,517
+1,630
| +184% | +$154K | 0.01% | 872 |
|
|
2016
Q1 | $143K | Sell |
887
-1,913
| -68% | -$174K | 0.02% | 570 |
|
|
2015
Q4 | $254K | Buy |
+2,800
| New | +$264K | 0.02% | 734 |
|
Other funds holding CME
IFP Advisors's CME Position: Q2 2026 in Review
IFP Advisors reduced its CME Group (CME) stake by 0.1% in Q2 2026, selling an estimated $830 and leaving 2,897 shares worth $640K. The position accounts for 0.01% of the portfolio, ranked #935.
IFP Advisors first reported a position in CME in Q4 2015 and has held it in 42 quarters since. The position peaked at $943K in Q2 2018. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- IFP Advisors held 2,897 shares of CME Group worth $640K as of Q2 2026.
- IFP Advisors sold 3 CME Group shares in Q2 2026, an estimated $830.
- CME Group made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #935 holding.
- IFP Advisors first reported a position in CME Group in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's CME Group position peaked at $943K in Q2 2018.
- 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.